Non-Invasive β-Thalassemia Diagnosis Using Cell FreeDNA Recovered from Blas tocele Fluid and Spent CultureMedium from Pre-Implantation Human Embryo

سال انتشار: 1401
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 128

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

RROYAN23_127

تاریخ نمایه سازی: 17 دی 1401

چکیده مقاله:

Background: To overcome the limitations of invasive embryobiopsy, a non-invasive alternative to preimplantation genetictes ting (PGT) has been recently introduced. This s tudy aimedto inves tigate the efficacy of cell-free DNA (CF-DNA) in thespent culture medium combined with blas tocoel fluid (ECB)versus blas tomere biopsy for β-thalassemia Diagnosis.Materials and Methods: This s tudy involved data from ۸ couples.A total of ۲۲ samples of ECB from fresh group who underwentPGT for β -thalassemia and ۶ ECB samples from donatedfrozen group and ۱۰ control media were collected and analyzed.Results: In fresh group, the HBB mutation analysis and haplotypingresults of ۹ of ۲۲ samples (۴۰.۹%) were concordant withthe biopsy results. The concordance rate in the donated frozengroup was higher than that in fresh group (۴/۶, ۶۶.۶%; P<۰.۰۵).۷۵% of markers were semi-informative. Marker failure ratewere significantly higher in fresh group (۳۴.۵% vs ۴.۸%;P<۰.۰۵). No significant relationship between allele dropout andfail number of all markers and embryo morphology was seen(P>۰.۰۵). Kappa- Agreement value between CF-DNA isolatedfrom culture media and blas tomere biopsy was ۰.۵۱۶ which ismoderate. The specificity, sensitivity, positive predictive value,and negative predictive value of CF-DNA to detect HBB mutationwere ۶۷, ۱۰۰, ۱۰۰, and ۶۷, respectively.Conclusion: We found that ECB for detecting β-thalassemia in donatedfrozen group was better than ECB in fresh group. Advancesin DNA extraction, amplification technique, and tes ting may allowfor PGT as a non-invasive approach without biopsy in the future.

نویسندگان

M Zare

Department of Reproductive Biology, Faculty of Basic Sciences andAdvanced Medical Technology, Royan Ins titute, ACECR, Tehran, Iran . Department of Embryology, Reproductive Biomedicine ResearchCenter, Royan Ins titute for Reproductive Biomedicine, ACECR,T

M Totonchi

Department of Genetics, Reproductive Biomedicine ResearchCenter, Royan Ins titute for Reproductive Biomedicine, ACECR,Tehran, Iran

H Gourabi

Department of Genetics, Reproductive Biomedicine ResearchCenter, Royan Ins titute for Reproductive Biomedicine, ACECR,Tehran, Iran

R Mohammadi

Genetic Laboratory of Shiraz Fertility Center, Shiraz FertilityCenter, Shiraz, Iran

R Pazhoomand

Genetic Laboratory of Shiraz Fertility Center, Shiraz FertilityCenter, Shiraz, Iran

P Eftekhari-Yazdi

Department of Embryology, Reproductive Biomedicine ResearchCenter, Royan Ins titute for Reproductive Biomedicine, ACECR,Tehran, Iran